Neurology scans for Alzheimer’s

Alzheimer’s disease is often linked to a buildup of abnormal proteins in the brain called amyloid plaques, which can interfere with how brain cells communicate and affect memory and thinking. A PET/CT scan is a simple, noninvasive imaging test that helps doctors see whether these plaques are present. Our advanced PET/CT technology uses a small amount of radiotracer to highlight amyloid in the brain, while the CT scan provides clear, detailed images of the brain’s structure. Together, these images give neurologists important answers that help confirm or rule out Alzheimer’s. If a patient is being evaluated for memory concerns, a neurologist can refer them for an amyloid PET/CT scan. Diagnostic accuracy is enhanced through the use of MIMNeuro Quantitative Analysis Software.  This analysis greatly improves diagnostic accuracy and confidence in findings. This confirmation is necessary before starting newly FDA-approved anti-amyloid treatments such as Leqembi® or Kisunla™, which may help reduce amyloid plaques in people with mild cognitive impairment or early Alzheimer’s.